Oliver Sartor, MD

Oliver Sartor, MD, Mayo Clinic

Articles by Oliver Sartor, MD

Oliver Sartor, MDRLT | November 21, 2024

Dr. Sartor offers insight on the efficacy of 177Lu-PSMA-617 in prolonging progression-free survival rates.

Oliver Sartor, MDCRPC | October 1, 2024

Dr. Oliver Sartor gives an overview of the SPLASH trial on PSMA-targeted therapies for patients with prostate cancer.

Oliver Sartor, MDRLT | June 18, 2024

Dr. Sartor discusses the PSMAfore study, which examined [177Lu]Lu-PSMA-617 radioligand therapy in taxane-naive mCRPC.

Oliver Sartor, MDRLT | December 4, 2023

Drs. Wallis and Sartor highlight issues with the control arm and considerations for treatment sequencing related to PSMAfore.

Oliver Sartor, MDRLT | December 4, 2023

Dr. Sartor explains in detail the design and methodology, specific findings, nuances, and implications of the PSMAfore trial.